GLI1 and melanoma: Likely, the Hh signaling pathway contributes to melanoma progression, as suggested by the delayed tumor growth of B16F0 melanoma cells in immunodeficient mice and also by tumor size reduction in a melanoma transgenic mouse model with elevated Gli-1 that was induced by oncogenic N-RAS when treated with Hh inhibitor [6].